Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 6661 to 6675 of 7680 results

  1. Idiopathic overactive bladder syndrome: botulinum toxin A (ESNM2)

    This evidence summary has been replaced by NICE guideline CG171.

    Evidence summary
    Published
    1 September 2012

  2. Type 2 diabetes: alogliptin (ESNM20)

    This evidence summary has been updated and replaced by NICE guideline NG28.

    Evidence summary
    Published
    21 May 2013

  3. Chronic obstructive pulmonary disease: fluticasone furoate plus vilanterol (ESNM21)

    This evidence summary has been updated and replaced by NICE guideline 115.

    Evidence summary
    Published
    18 June 2013

  4. Asthma: beclometasone/formoterol (Fostair) for maintenance and reliever treatment (ESNM22)

    This evidence summary has been updated and replaced by NICE guideline NG80.

    Evidence summary
    Published
    25 June 2013

  5. Gouty arthritis: canakinumab (ESNM23)

    This advice has been updated and replaced by NICE guideline NG219.

    Evidence summary
    Published
    23 July 2013

  6. Type 1 diabetes: insulin degludec (ESNM24)

    This evidence summary has been updated and replaced by NICE guideline NG17.

    Evidence summary
    Published
    10 September 2013

  7. Type 2 diabetes: lixisenatide (ESNM26)

    This evidence summary has been updated and replaced by NICE guideline NG28.

    Evidence summary
    Published
    24 September 2013

  8. Secondary prevention in acute coronary syndrome: rivaroxaban (ESNM27)

    This evidence summary has been replaced by NICE technology appraisal guidance 335

    Evidence summary
    Published
    29 October 2013

  9. Myocardial infarction (acute): Early rule out using high-sensitivity troponin tests (Elecsys Troponin T high-sensitive, ARCHITECT STAT High Sensitive Troponin-I and AccuTnI+3 assays) (DG15)

    This guidance has been updated and replaced by NICE diagnostics guidance 40.

    Diagnostics guidance
    Published
    1 October 2014

  10. Transobturator foramen procedures for stress urinary incontinence (IPG107)

    The National Institute for Health and Clinical Excellence (NICE) issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on transobturator foramen procedures for stress incontinence in January 2005. This guidance has been withdrawn as the use of this procedure is now covered in NICE guideline CG40. NICE has no plans to carry out further assessment of this procedure under the Interventional Procedures Programme.

    Interventional procedures guidance
    Published
    23 January 2005

  11. Percutaneous closure of patent foramen ovale for the secondary prevention of recurrent paradoxical embolism (IPG109)

    This guidance has been replaced by NICE interventional procedure guidance 472.

    Interventional procedures guidance
    Published
    23 January 2005

  12. Stereotactic radiosurgery for trigeminal neuralgia using the gamma knife (IPG11)

    This guidance has been updated and replaced by NICE interventional procedure guidance 85.

    Interventional procedures guidance
    Published
    23 September 2003

  13. Endoluminal gastroplication for gastro-oesophageal reflux disease (IPG115)

    This guidance has been updated and replaced by NICE interventional procedure guidance 404.

    Interventional procedures guidance
    Published
    23 February 2005

  14. Minimally invasive two-incision surgery for total hip replacement (IPG112)

    This guidance has been updated and replaced by NICE interventional procedure guidance 363.

    Interventional procedures guidance
    Published
    23 February 2005

  15. Complete cytoreduction and heated intraperitoneal intraoperative chemotherapy (Sugarbaker technique) for peritoneal carcinomatosis (IPG116)

    This guidance has been updated and replaced by NICE interventional procedure guidance 331.

    Interventional procedures guidance
    Published
    23 March 2005